Plain-English translation of NCT04532606 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial compares two anesthesia medications used during bladder cancer surgery. One group receives , a newer anesthesia drug that works quickly and leaves your body fast, while the other group receives , a standard anesthesia medication. Researchers want to see if might help prevent cancer from coming back and reduce confusion that sometimes happens after surgery.
Lab studies suggest that certain anesthesia drugs may help slow cancer cell growth, but doctors don't yet know if this helps real patients after surgery. This medication leaves the body very quickly, which might also prevent the confusion and delirium that can happen after anesthesia — a common problem that affects recovery.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of two anesthesia medications during your scheduled bladder tumor removal surgery. The surgical team will monitor your anesthesia depth during the procedure using a special sensor. After surgery, researchers will track whether you experience confusion or delirium during your hospital stay and will follow your health for a period of time to see if your cancer comes back.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China